AIMMUNE THERAPEUTICS INC's ticker is AIMT and the CUSIP is 00900T107. A total of 167 filers reported holding AIMMUNE THERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is 0.64 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2020 | $927,000 | +30.6% | 55,502 | +12.5% | 0.00% | 0.0% |
Q1 2020 | $710,000 | +16.0% | 49,334 | +92.6% | 0.00% | +100.0% |
Q4 2018 | $612,000 | -11.3% | 25,614 | +1.4% | 0.00% | 0.0% |
Q3 2018 | $690,000 | +34.5% | 25,251 | +32.6% | 0.00% | 0.0% |
Q2 2018 | $513,000 | -15.2% | 19,036 | 0.0% | 0.00% | 0.0% |
Q1 2018 | $605,000 | -51.8% | 19,036 | -41.2% | 0.00% | -50.0% |
Q4 2017 | $1,255,000 | -23.8% | 32,377 | -51.3% | 0.00% | -33.3% |
Q3 2017 | $1,648,000 | +209.8% | 66,454 | +156.6% | 0.00% | +200.0% |
Q2 2017 | $532,000 | -24.9% | 25,897 | -20.5% | 0.00% | 0.0% |
Q1 2017 | $708,000 | -58.6% | 32,579 | -60.9% | 0.00% | -66.7% |
Q4 2016 | $1,711,000 | – | 83,336 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|